GLP-1 drugs are revolutionizing the treatment of obesity and diabetes. Here's what to know about investing in GLP-1 stocks.

Liraglutide, a medication commonly used to treat diabetes, has shown promising results in reducing chronic migraine in ...

GLP-1 weight loss patches are everywhere but do they actually work as these trendy patches promise Ozempic-like results ...

More than 90% of patients achieved clinically meaningful weight reduction compared to placebo in a phase 3 trial of ecnoglutide.

A new potential drug treatment for people with type 2 diabetes and obesity lowers blood sugar and increases fat burning.

In his new book, a former FDA commissioner unpacks the latest science on metabolism, weight loss, and how GLP-1 drugs ...

showing that they could predict which obese people were likely to respond better to liraglutide — the GLP-1 agonist in Victoza, which resembles the GLP-1 agonists in Wegovy and Mounjaro — and ...

Biomea Fusion Reports Preclinical Data for BMF-650, a Next-Generation Oral GLP-1 Receptor Agonist Candidate, Demonstrating Robust Weight Loss and Appetite Suppression in Obese Non-Human Primates ...